BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pawelec G, McElhaney J. Recent advances in influenza vaccines. F1000Res 2020;9:F1000 Faculty Rev-305. [PMID: 32399192 DOI: 10.12688/f1000research.22611.1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Leibinger EA, Pauler G, Benedek N, Berki T, Jankovics I, McNally R, Ottóffy G. Baseline CD3+CD56+ (NKT-like) Cells and the Outcome of Influenza Vaccination in Children Undergoing Chemotherapy. Front Immunol 2021;12:690940. [PMID: 34267757 DOI: 10.3389/fimmu.2021.690940] [Reference Citation Analysis]
2 Mezhenskaya D, Isakova-Sivak I, Kotomina T, Matyushenko V, Kim MC, Bhatnagar N, Kim KH, Kang SM, Rudenko L. A Strategy to Elicit M2e-Specific Antibodies Using a Recombinant H7N9 Live Attenuated Influenza Vaccine Expressing Multiple M2e Tandem Repeats. Biomedicines 2021;9:133. [PMID: 33535408 DOI: 10.3390/biomedicines9020133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Rockman S, Taylor B, Mccauley JW, Barr IG, Longstaff R, Bahra R. Global Pandemic Preparedness: Optimizing Our Capabilities and the Influenza Experience. Vaccines 2022;10:589. [DOI: 10.3390/vaccines10040589] [Reference Citation Analysis]
4 Lewis NS, Banyard AC, Essen S, Whittard E, Coggon A, Hansen R, Reid S, Brown IH. Antigenic evolution of contemporary clade 2.3.4.4 HPAI H5 influenza A viruses and impact on vaccine use for mitigation and control. Vaccine 2021;39:3794-8. [PMID: 34074548 DOI: 10.1016/j.vaccine.2021.05.060] [Reference Citation Analysis]
5 Constantin C, Pisani A, Bardi G, Neagu M. Nano-carriers of COVID-19 vaccines: the main pillars of efficacy. Nanomedicine (Lond) 2021;16:2377-87. [PMID: 34632802 DOI: 10.2217/nnm-2021-0250] [Reference Citation Analysis]
6 Gilroy DW, De Maeyer RPH, Tepper M, O'Brien A, Uddin M, Chen J, Goldstein DR, Akbar AN. Treating exuberant, non-resolving inflammation in the lung; Implications for acute respiratory distress syndrome and COVID-19. Pharmacol Ther 2021;221:107745. [PMID: 33188794 DOI: 10.1016/j.pharmthera.2020.107745] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]